FTY-720

被引：5
|
作者：
不详
机构：
来源：
DRUGS OF THE FUTURE | 2002年 / 27卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
FTY-720 (Mitsubishi Pharma, Taito, Novartis) is a novel immunosuppressant which is currently undergoing phase II trials for organ transplantation. The compound represents a novel concept in immunosuppression, protecting the transplant against T-cells without affecting the host's ability to respond to antigens.
引用
收藏
页码：501 / 506
页数：6
相关论文
共 50 条
  • [1] FTY-720 -: Treatment of transplant rejection immunosuppressant
    不详
    DRUGS OF THE FUTURE, 2001, 26 (01) : 74 - 78
  • [2] FTY-720 is efficacious in monkey kidney transplantation
    Quesniaux, V
    Menninger, K
    Audet, M
    Gaschen, L
    Schuurman, HJ
    TRANSPLANTATION PROCEEDINGS, 2001, 33 (03) : 2374 - 2375
  • [3] A new efficient synthesis of the immunosuppressive agent FTY-720
    Durand, P
    Peralba, P
    Sierra, F
    Renaut, P
    SYNTHESIS-STUTTGART, 2000, (04): : 505 - 506
  • [4] Therapeutic potential of FTY-720 for treating cardiac hypertrophic remodeling
    Wang, Xin
    Liu, Wei
    Zi, Min
    Naumann, Ronald
    Xiao, Rui-ping
    Neyses, Ludwig
    Solaro, R. John
    Ke, Yun-bo
    Cartwright, Elizabeth J.
    Lei, Ming
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 72 - 72
  • [5] FTY-720 induces apoptosis in neuroblastoma via multiple signaling pathways
    Lange, Ingo
    Espinoza-Fuenzalida, Italo
    Ali, Mourad Wagdy
    Serrano, Laura Espana
    Koomoa, Dana-Lynn T.
    ONCOTARGET, 2017, 8 (66) : 109985 - 109999
  • [6] Transcriptomic analysis of disease reversal in EAE: comparison of laquinimod and FTY-720
    Belinson, H.
    Barash, S.
    Kaye, J.
    Raymond, E.
    Laifenfeld, D.
    Laufer, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 177 - 177
  • [7] 新型免疫抑制剂FTY-720的合成
    梁铁
    路海滨
    徐志炳
    米浩宇
    吴鹏飞
    崔磊
    王恩思
    吉林大学学报(理学版), 2008, (01) : 139 - 142
  • [8] Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells
    Yolanda Gimenez-Molina
    Virginia García-Martínez
    José Villanueva
    Bazbek Davletov
    Luis M. Gutiérrez
    Scientific Reports, 9
  • [9] Multiple sclerosis drug FTY-720 toxicity is mediated by the heterotypic fusion of organelles in neuroendocrine cells
    Gimenez-Molina, Yolanda
    Garcia-Martinez, Virginia
    Villanueva, Jose
    Davletov, Bazbek
    Gutierrez, Luis M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [10] FTY-720 alleviates diabetes-induced liver injury by inhibiting oxidative stress and inflammation
    Ye, Huijing
    Sun, Mengyao
    Jin, Zijie
    Yuan, Yan
    Weng, Hongbo
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 (05) : 960 - 970
12345